SYRS

Syros Pharmaceuticals (SYRS)

Syros Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SYRS
DateTimeSourceHeadlineSymbolCompany
05/16/20224:55PMTipRanksSyros Pharmaceuticals (SYRS) Receives a Buy from Alliance Global Partners NASDAQ:SYRSSyros Pharmaceuticals Inc
05/16/20227:30AMBusiness WireSyros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update NASDAQ:SYRSSyros Pharmaceuticals Inc
05/16/20227:03AMEdgar (US Regulatory)Quarterly Report (10-q) NASDAQ:SYRSSyros Pharmaceuticals Inc
05/09/20227:30AMBusiness WireSyros to Report First Quarter 2022 Financial Results on Monday, May 16, 2022 NASDAQ:SYRSSyros Pharmaceuticals Inc
04/29/20224:01PMBusiness WireSyros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NASDAQ:SYRSSyros Pharmaceuticals Inc
04/25/202210:29AMTipRanksThese 2 Penny Stocks Could Rally to $15 (Or More), Says Roth Capital NASDAQ:SYRSSyros Pharmaceuticals Inc
04/21/20227:06AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a) NASDAQ:SYRSSyros Pharmaceuticals Inc
04/20/202211:01AMTipRanksThese 2 Penny Stocks Could Rally to $15 (Or More), Says Roth Capital NASDAQ:SYRSSyros Pharmaceuticals Inc
04/11/20229:03AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a) NASDAQ:SYRSSyros Pharmaceuticals Inc
04/08/20228:30PMTipRanksBrookline Capital Markets Thinks Syros Pharmaceuticals’ Stock is Going to Recover NASDAQ:SYRSSyros Pharmaceuticals Inc
04/08/20221:00PMBusiness WireSyros Presents New Preclinical Data on its CDK12 Inhibitor Program at American Association for Cancer Research (AACR) Annual Meeting 2022 NASDAQ:SYRSSyros Pharmaceuticals Inc
04/01/20224:01PMBusiness WireSyros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NASDAQ:SYRSSyros Pharmaceuticals Inc
03/16/202211:35AMTipRanksAlliance Global Partners Sticks to Their Buy Rating for Syros Pharmaceuticals (SYRS) NASDAQ:SYRSSyros Pharmaceuticals Inc
03/16/20226:56AMTipRanksH.C. Wainwright Thinks Syros Pharmaceuticals’ Stock is Going to Recover NASDAQ:SYRSSyros Pharmaceuticals Inc
03/15/202212:45PMTipRanksJMP Securities Keeps a Buy Rating on Syros Pharmaceuticals (SYRS) NASDAQ:SYRSSyros Pharmaceuticals Inc
03/15/20228:03AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8) NASDAQ:SYRSSyros Pharmaceuticals Inc
03/15/20227:37AMSeeking AlphaSyros Pharmaceuticals GAAP EPS of -$0.38 beats by $0.08, revenue of $78M beats by $73.16M NASDAQ:SYRSSyros Pharmaceuticals Inc
03/15/20227:32AMBusiness WireSyros Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones NASDAQ:SYRSSyros Pharmaceuticals Inc
03/15/20227:28AMEdgar (US Regulatory)Annual Report (10-k) NASDAQ:SYRSSyros Pharmaceuticals Inc
03/14/202212:28PMSeeking AlphaSyros Pharmaceuticals Q4 2021 Earnings Preview NASDAQ:SYRSSyros Pharmaceuticals Inc
03/09/20227:30AMBusiness WireSyros to Report Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 15, 2022 NASDAQ:SYRSSyros Pharmaceuticals Inc
03/08/20224:31PMBusiness WireSyros to Present New Preclinical Data on its CDK12 Inhibitor Program at the American Association for Cancer Research (AACR) Annual Meeting 2022 NASDAQ:SYRSSyros Pharmaceuticals Inc
03/08/20222:15PMTipRanksJMP Securities Thinks Syros Pharmaceuticals’ Stock is Going to Recover NASDAQ:SYRSSyros Pharmaceuticals Inc
03/08/20227:02AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:SYRSSyros Pharmaceuticals Inc
02/28/20227:30AMBusiness WireSyros to Participate in Upcoming Virtual Investor Conferences in March NASDAQ:SYRSSyros Pharmaceuticals Inc
02/17/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:SYRSSyros Pharmaceuticals Inc
02/17/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:SYRSSyros Pharmaceuticals Inc
02/17/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:SYRSSyros Pharmaceuticals Inc
02/17/20224:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:SYRSSyros Pharmaceuticals Inc
02/17/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:SYRSSyros Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SYRS
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220519 11:45:50